Jan Eickhoff studied biochemistry at the University Bayreuth and Imperial College in London, followed by PhD studies at the Max-Planck-Institute of Biochemistry in Martinsried. He started his industrial career in 2001 at Axxima Pharmaceuticals, and GPC Biotech, before he moved to Dortmund in 2008 to build up the screening and sample management department of the Lead Discovery Center GmbH (LDC). Furthermore, he was involved in conceptual planning and implementation of the compound management and screening center of the Max-Planck-Society (COMAS). In addition to his role as a Head of Assay Development and Screening at the LDC, from 2013 to 2015 he was holding a role as managing director of the Hit Discovery Constance GmbH in Constance, Germany.